Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting G-CSF for Febrile Neutropenia in Ovarian Cancer
NCT03740464Phase 3Unknown
- Start
- Nov 2018
- Primary completion
- Nov 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of pegfilgrastim in febrile neutropenia (FN). Status: unknown.
02
Drugs
pegfilgrastim
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT03740464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740464.